All news
Low ImpactRegulation

Concord Biotech shares to remain suspended pending publication

Concord Biotech shares will remain suspended on the NSE pending the newspaper publication as per regulatory requirements. The company has published the notice to comply with listing obligations. No financial impact is indicated at this stage. Traders should monitor for resumption of trading.

📊 STOCKS: CONCORDBIO | 🏢 SECTOR: Pharma | #LOWIMPACT #suspension

#suspension#publication#regulatory
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.